促炎细胞因子
炎症
癌症研究
IκB激酶
动脉发生
组蛋白脱乙酰基酶
免疫学
生物
NF-κB
细胞生物学
医学
组蛋白
血管生成
生物化学
基因
作者
Yaw Asare,Thomas A. Campbell-James,Yury Bokov,Lydia Luya Yu,Matthias Prestel,Omar El Bounkari,Stefan Roth,Remco T. A. Megens,Tobias Straub,Kyra Thomas,Guangyao Yan,Melanie Schneider,Natalie Ziesch,Steffen Tiedt,Carlos Silvestre-Roig,Quinte Braster,Yishu Huang,Manuela Schneider,Rainer Malik,Christof Haffner
出处
期刊:Circulation Research
[Lippincott Williams & Wilkins]
日期:2020-06-17
卷期号:127 (6): 811-823
被引量:115
标识
DOI:10.1161/circresaha.120.316743
摘要
RATIONALE: Arterial inflammation manifested as atherosclerosis is the leading cause of mortality worldwide. Genome-wide association studies have identified a prominent role of HDAC (histone deacetylase)-9 in atherosclerosis and its clinical complications including stroke and myocardial infarction. OBJECTIVE: To determine the mechanisms linking HDAC9 to these vascular pathologies and explore its therapeutic potential for atheroprotection. METHODS AND RESULTS: deficiency reduces lesional macrophage content while increasing fibrous cap thickness thus conferring plaque stability. We demonstrate that HDAC9 binds to IKK (inhibitory kappa B kinase)-α and β, resulting in their deacetylation and subsequent activation, which drives inflammatory responses in both macrophages and endothelial cells. Pharmacological inhibition of HDAC9 with the class IIa HDAC inhibitor TMP195 attenuates lesion formation by reducing endothelial activation and leukocyte recruitment along with limiting proinflammatory responses in macrophages. Transcriptional profiling using RNA sequencing revealed that TMP195 downregulates key inflammatory pathways consistent with inhibitory effects on IKKβ. TMP195 mitigates the progression of established lesions and inhibits the infiltration of inflammatory cells. Moreover, TMP195 diminishes features of plaque vulnerability and thereby enhances plaque stability in advanced lesions. Ex vivo treatment of monocytes from patients with established atherosclerosis reduced the production of inflammatory cytokines including IL (interleukin)-1β and IL-6. CONCLUSIONS: Our findings identify HDAC9 as a regulator of atherosclerotic plaque stability and IKK activation thus providing a mechanistic explanation for the prominence of HDAC9 as a vascular risk locus in genome-wide association studies. Its therapeutic inhibition may provide a potent lever to alleviate vascular inflammation. Graphical Abstract: A graphical abstract is available for this article.
科研通智能强力驱动
Strongly Powered by AbleSci AI